Tenderwize
Retour à la recherche

Open House Originale Propranolol Oral Solution

Techniker Krankenkasse·Hamburg, Germany·Deadline Dec 30, 2027 · 491 days left·Open·Supplies
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-33 - Propranolol (Darreichungsform: Lösung zum Einnehmen)

62/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

62 / 100

Complexité

58 / 100

Facteurs de risque

The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...

Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Dec 2027
  • Supply of pharmaceutical products, specifically Propranolol in oral solution form.
  • Open-house contract model with uniform conditions and no individual negotiations.
Afficher le résumé complet

This is an open-house style supply arrangement for Propranolol oral solution in Germany, led by Techniker Krankenkasse with hkk and HEK as participating buyers. The notice states that all suitable pharmaceutical companies may join during the contract period under uniform conditions, with no exclusivity and no individual negotiations. No contract value is provided. Submission is not via the portal; contracts must be sent by email with qualified electronic signature or by post, and the participation documents are only available electronically via the buyer portal. The extracted documents were analyzed, but the actual participation/contract documents themselves were not provided.

Risques

The notice says offers/contracts cannot be submitted via the procurement portal; they must be sent by email with qualif...

Only pharmaceutical undertakings for the relevant product, with the required seat and authorization status, may partici...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Applicant must be a pharmaceutical undertaking within the meaning of § 4(18) AMG for the relevant product.
  • Applicant must have its seat in Germany, another EU Member State, or an EEA state.
  • Applicant must hold a valid marketing authorization for the relevant medicinal product, or otherwise be entitled to place it on the market in its own name.

Acheteur

Localisation

Hamburg, DEU

Identifiant

992-80116-93

Activité

Health

Lots (1)

LOT-0001

Open House Originale Propranolol Oral Solution

Supply arrangement for Propranolol in oral solution form. The lot is described as a nationwide open-house contract under § 130c SGB V, with uniform terms for all eligible pharmaceutical companies. The extracted notice text indicates that participation documents are only provided to companies that market, or can credibly demonstrate they will market, the relevant medicinal product during the contract period.

SuppliesEU fundedElectronic submission

Localisation

DE600, Germany

Durée

Dec 2025 - Dec 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Dec 30, 2027

Détails de la procédure

Date de publication
19 Oct 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
689646-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3